Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study

Table 6 IL-6 levels during the inpatient stay according to functional outcome at discharge (dichotomized modified Rankin scale score)

	Minimum	Maximum	Mean	SD	95 % CI	Number
IL-6 day 0
Favorable	<2	109	12	20	6, 18	38
Unfavorable	<2	529	37	86	9, 66	37
IL-6 day 1
Favorable	<2	122	18	22	11, 25	37
Unfavorable	3	194	35	40	21, 49	35
IL-6 day 4
Favorable	<2	175	14	30	4, 25	36
Unfavorable	<2	878	63	160	5, 120	32
IL-6 day 7
Favorable	<2	53	12	14	7, 16	35
Unfavorable	<2	413	51	84	20, 82	31
IL-6 day 10
Favorable	<2	33	8	8	5, 11	35
Unfavorable	3	241	34	50	15, 53	28
IL-6 day 14
Favorable	<2	30	6	6	4, 9	29
Unfavorable	2	905	65	181	−12, 141	24

IL-6 levels (pg/ml) during the acute stage of disease according to dichotomized (Favorable vs Unfavorable) outcome at discharge. Number number of cases analyzed

ISSN: 1364-8535